At Pack Expo, MG America to Debut Latest Cartoner from Cariba

Cariba C221 is an intermittent motion, side-load cartoner capable of producing 120 cartons per minute

MG America, the U.S. subsidiary of MG2 of Bologna, Italy and a leading supplier of processing and packaging equipment, will introduce to the North American market the latest cartoner from established pharma machinery provider Cariba at Pack Expo, October 23-26 in Chicago. At Booth W-15003, MG America will showcase the new Cariba C221 Cartoner, an intermittent motion horizontal model capable of producing up to 120 cartons/min.

With picking-arm enabled positive carton forming, the Cariba C2221 is suitable for pharmaceutical, nutraceutical and cosmetics application. The unit is available either with a manual feeding station or a variety of automatic product feeders. In either configuration, the Cariba C221 is compatible with a broad range of common primary packaging formats, including blister packs, round/shaped glass and plastic bottles, jars, soft tubes, flow packs, sachets, and stick packs.

Changeover is fast, and based mainly on adjustments rather than replacements. Tuck-in and hot-melt closures are available, with a combination of the two providing tamper evidence. Printing options include emboss, inkjet and laser coding, and the unit comes equipped with integrated barcode-reading capabilities.

The Cariba C2221’s balcony-style design ensures easy cleaning and maintenance, as well as separation between electrical and mechanical sections. Its lowered carton magazine, full servo assisted motions, controlled adjustable transportation and coated guides combine to eliminate marking on components.

The Cariba C221 can be customized with a variety of additional features, including extended carton magazines, pre-folded leaflets and booklet dispensers, leaflet folding units (GUK), serialization-ready external modules, and remote connectivity.

“In a pharmaceutical manufacturing landscape that increasingly demands functional flexibility, the Cariba C221 offers unsurpassed versatility in its cartoning class,” said Claudio Radossi, President of MG America. “We look forward to showcasing it, as well as several other packaging and processing solutions, at this year’s Pack Expo.”

Over more than 35 years of business, Cariba has developed an outstanding reputation for its wide range of machinery, which includes cartoners, closing machines, case packers and complete line solutions. Cariba serves a broad swath of packaging sectors, including pharmaceuticals, cosmetics, food, consumer electronics and household and cleaning products.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.